BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2867942)

  • 1. Altered activation by calcitonin and inhibition by somatostatin of human embryonal carcinoma cell adenylate cyclase with retinoic acid-induced differentiation.
    Liapi C; Anderson WB; Evain-Brion D
    Dev Biol; 1986 Jan; 113(1):141-6. PubMed ID: 2867942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered hormonal responses: markers for embryonal and embryonic carcinoma stem cells and their differentiated derivatives.
    Liapi C; Gerbaud P; Anderson WB; Brion DE
    J Cell Physiol; 1987 Nov; 133(2):405-8. PubMed ID: 3680397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin-responsive adenylate cyclase in cultured F9 embryonal carcinoma cells.
    Binet E; Evain D; Anderson WB
    Exp Cell Res; 1980 Oct; 129(2):466-9. PubMed ID: 6253308
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations in calcitonin and parathyroid hormone responsiveness of adenylate cyclase in F9 embryonal carcinoma cells treated with retinoic acid and dibutyryl cyclic AMP.
    Evain D; Binet E; Anderson WB
    J Cell Physiol; 1981 Dec; 109(3):453-9. PubMed ID: 6274880
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of immunoreactive calcitonin and parathyroid hormone by embryonal carcinoma cells: alteration with retinoic acid-induced differentiation.
    Evain-Brion D; Binet E; Donnadieu M; Laurent P; Anderson WB
    Dev Biol; 1984 Aug; 104(2):406-12. PubMed ID: 6745491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi.
    Gordeladze JO; Björo T; Torjesen PA; Ostberg BC; Haug E; Gautvik KM
    Eur J Biochem; 1989 Aug; 183(2):397-406. PubMed ID: 2569396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone-sensitive adenylate cyclase of prolactin-producing rat pituitary adenoma (GH4C1) cells: molecular organization.
    Gordeladze JO; Sletholt K; Thorn NA; Gautvik KM
    Eur J Biochem; 1988 Nov; 177(3):665-72. PubMed ID: 2904368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
    Chan SD; Strewler GJ; King KL; Nissenson RA
    Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of parathyroid hormone- and calcitonin-activated adenylate cyclases in embryonic chicken limb and in cultured cells from embryonic chicken limb.
    Zull JE; Krug S; Abel D; Caplan AI
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3871-5. PubMed ID: 279002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin-sensitive adenylate cyclase in rat renal tubular membranes.
    Loreau N; Lepreux C; Ardaillou R
    Biochem J; 1975 Sep; 150(3):305-14. PubMed ID: 2153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pertussis toxin on adenylate cyclase responses to prostaglandin E2 and calcitonin in human breast cancer cells.
    Michelangeli VP; Livesey SA; Martin TJ
    Biochem J; 1984 Dec; 224(2):371-7. PubMed ID: 6097215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of a hormone-sensitive inhibitory coupling component of the adenylate cyclase in S49 lymphoma cyc- variants.
    Jakobs KH; Schultz G
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3899-902. PubMed ID: 6135205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells.
    Jakobs KH; Aktories K; Schultz G
    Nature; 1983 May 12-18; 303(5913):177-8. PubMed ID: 6133220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.
    Hunt NH; Ellison M; Underwood JC; Martin TJ
    Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin inhibits growth hormone-releasing factor-stimulated adenylate cyclase activity in GH, cells.
    Reyl-Desmars F; Zeytin F
    Biochem Biophys Res Commun; 1985 Mar; 127(3):986-91. PubMed ID: 2859018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for receptor-regulated phosphotransfer reactions involved in activation of the adenylate cyclase inhibitory G protein in human platelet membranes.
    Jakobs KH; Wieland T
    Eur J Biochem; 1989 Jul; 183(1):115-21. PubMed ID: 2502397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRF is a highly potent activator of adenylate cyclase in the normal human, bovine and rat pituitary: interaction with somatostatin.
    Reyl-Desmars F; Baird A; Zeytin FN
    Biochem Biophys Res Commun; 1985 Mar; 127(3):977-85. PubMed ID: 2859017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of human neuroblastoma cells: marked potentiation of prostaglandin E-stimulated accumulation of cyclic AMP by retinoic acid.
    Yu VC; Hochhaus G; Chang FH; Richards ML; Bourne HR; Sadée W
    J Neurochem; 1988 Dec; 51(6):1892-9. PubMed ID: 2903224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations.
    Markstein R; Stöckli KA; Reubi JC
    Neurosci Lett; 1989 Sep; 104(1-2):13-8. PubMed ID: 2573010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin inhibition of adenylate cyclase activity in different brain areas.
    Schettini G; Florio T; Meucci O; Landolfi E; Grimaldi M; Ventra C; Marino A
    Brain Res; 1989 Jul; 492(1-2):65-71. PubMed ID: 2568880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.